Daratumumab Supplier from India: A Comprehensive Guide for Global Pharmaceutical Importers
The global demand for advanced oncology therapies continues to grow as healthcare providers seek innovative treatment options for complex hematological cancers. Among these therapies, Daratumumab medicine has become an essential monoclonal antibody used in modern treatment protocols for multiple myeloma and other plasma cell disorders.
As international procurement teams, pharmaceutical distributors, hospitals, and government healthcare agencies expand access to specialty medicines, India has emerged as one of the preferred sourcing destinations due to its robust pharmaceutical infrastructure, regulatory expertise, and global export capabilities.
This guide explores everything international buyers should know about sourcing Daratumumab from India, including its therapeutic applications, product specifications, regulatory requirements, logistics considerations, and the key factors to evaluate when selecting a reliable export partner.
What Is Daratumumab?
Daratumumab is a human monoclonal antibody designed to target the CD38 protein, which is highly expressed on the surface of multiple myeloma cells. By binding to CD38, Daratumumab helps the body’s immune system recognize and eliminate malignant plasma cells through multiple immune-mediated mechanisms.
Today, Daratumumab is widely incorporated into treatment guidelines for several plasma cell disorders and has become an important component of immunotherapy-based oncology care.
Its ability to improve treatment outcomes has made it one of the most sought-after specialty oncology medicines in international pharmaceutical procurement.
Clinical Applications of Daratumumab
Daratumumab is prescribed by qualified healthcare professionals as part of individualized treatment plans for eligible patients.
Common therapeutic indications include:
- Multiple Myeloma
- Newly Diagnosed Multiple Myeloma (NDMM)
- Relapsed Multiple Myeloma
- Refractory Multiple Myeloma
- Relapsed or Refractory Multiple Myeloma (RRMM)
- Light-Chain (AL) Amyloidosis
Depending on clinical requirements, Daratumumab may be administered as a standalone therapy or in combination with other anti-cancer medicines, corticosteroids, proteasome inhibitors, or immunomodulatory agents.
Because treatment protocols vary according to disease stage and patient condition, administration should always be supervised by experienced oncology specialists.
Why International Buyers Source Daratumumab from India
India has established itself as a major global supplier of pharmaceutical products, serving healthcare systems across regulated and semi-regulated markets.
For international buyers, sourcing Daratumumab from India offers several advantages:
Strong Pharmaceutical Manufacturing Ecosystem
India is home to internationally recognized pharmaceutical manufacturers operating under stringent quality standards and supplying medicines to healthcare institutions across the world.
Reliable Export Infrastructure
Experienced pharmaceutical exporters provide comprehensive support throughout the procurement process, from product sourcing and documentation to customs coordination and international logistics.
Regulatory Expertise
International shipments often require extensive regulatory documentation. Experienced exporters assist buyers in preparing the necessary paperwork to facilitate smoother import clearance.
Efficient Global Supply Chains
Established logistics networks enable temperature-sensitive oncology products to be transported safely while maintaining product integrity throughout transit.
Product Information
| Specification | Details |
|---|---|
| Generic Name | Daratumumab |
| Dosage Form | Solution for Injection / Intravenous Infusion |
| Available Strengths | 100 mg/5 mL, 400 mg/20 mL |
| Packaging | Single-Dose Vial |
| Therapeutic Category | Oncology, Hematology, Immunotherapy |
| Drug Class | Monoclonal Antibody |
Product availability may vary depending on manufacturing schedules, destination-country regulations, and procurement requirements.
Who Procures Daratumumab?
The international demand for Daratumumab extends across various healthcare sectors. Typical buyers include:
- Pharmaceutical importers
- National pharmaceutical distributors
- Hospital procurement departments
- Oncology specialty hospitals
- Government healthcare organizations
- International NGOs
- Medical procurement agencies
- Healthcare supply chain companies
- Specialty pharmaceutical wholesalers
Large-scale procurement often requires advance planning due to product demand, import approvals, and cold-chain logistics.
Global Markets Served
International pharmaceutical suppliers from India support healthcare organizations across numerous global regions. These include:
| Latin America (LATAM) | Central America | Caribbean | Africa |
|---|---|---|---|
| Brazil Argentina Chile Peru Colombia Ecuador Uruguay Bolivia | Costa Rica Guatemala Panama Honduras Nicaragua Belize El Salvador | Dominican Republic Cuba Haiti Puerto Rico | Nigeria Kenya Ghana Ethiopia South Africa Namibia Senegal Madagascar Chad |
Export availability remains subject to local import regulations and product registration requirements.
Factors to Consider When Choosing a Daratumumab Supplier
Selecting the right pharmaceutical export partner involves more than comparing prices.
International buyers should evaluate several important factors before placing procurement orders.
Product Quality
Ensure products are sourced through legitimate pharmaceutical supply channels while complying with applicable quality standards.
Regulatory Documentation
Reliable suppliers should be able to coordinate documentation required by importing authorities.
Cold Chain Management
Temperature-sensitive oncology medicines require controlled storage and transportation throughout the supply chain.
Export Experience
An experienced pharmaceutical exporter understands international documentation, customs procedures, and country-specific import requirements.
Consistent Supply
Long-term procurement partners should be capable of supporting recurring supply requirements while minimizing disruptions.
Regulatory Documentation for International Procurement
Every destination country has unique regulatory requirements. Depending on market regulations and product availability, documentation may include:
- Certificate of Analysis (COA)
- Certificate of Origin (COO)
- Free Sale Certificate (FSC), where applicable
- WHO-GMP documentation, where available
- Commercial Invoice
- Packing List
- Batch-related quality documents
- Temperature monitoring records (where applicable)
- Additional country-specific documentation required by health authorities
Proper documentation helps streamline customs clearance and supports regulatory compliance during import.
Cold Chain Logistics for Oncology Medicines
Maintaining product quality throughout transportation is critical for temperature-sensitive biologic medicines. Professional pharmaceutical exporters typically support:
- GDP-compliant logistics
- Temperature-controlled transportation
- Validated insulated packaging
- Air freight and sea freight solutions
- Continuous shipment monitoring
- Secure international delivery coordination
Appropriate logistics planning helps preserve product stability from dispatch to final destination.
Why Procurement Teams Choose Ikris Health Plus
International buyers require more than a product supplier—they need a dependable sourcing partner capable of supporting complex procurement requirements.
Ikris Health Plus works with pharmaceutical importers, distributors, hospitals, wholesalers, and healthcare organizations by providing access to specialty medicines sourced through an established pharmaceutical network.
Our procurement support includes:
- Global sourcing of oncology and specialty medicines
- Assistance with international pharmaceutical procurement
- Export coordination for multiple global markets
- Regulatory documentation support
- Reliable communication throughout the sourcing process
- Cold-chain logistics coordination where required
- Responsive support for institutional and bulk procurement inquiries
With a customer-focused approach and extensive experience in international pharmaceutical supply, Ikris Health Plus strives to simplify the procurement process for healthcare organizations across the globe.
Request a Daratumumab Procurement Quote
Whether you represent a pharmaceutical importing company, hospital procurement department, healthcare organization, or authorized distributor, sourcing Daratumumab requires careful coordination between quality, documentation, logistics, and regulatory compliance.
Ikris Health Plus supports international buyers by assisting with procurement inquiries, export documentation, and global supply coordination for specialty oncology medicines.
For product availability, procurement support, or export-related information, contact our team to discuss your sourcing requirements.
Frequently Asked Questions
Is Daratumumab available for international procurement from India?
Yes. Subject to regulatory approvals and destination-country requirements, Daratumumab can be sourced for eligible international markets through experienced pharmaceutical exporters.
What is Daratumumab primarily used for?
Daratumumab is primarily used in the treatment of multiple myeloma and certain plasma cell disorders as part of immunotherapy-based treatment protocols.
Who typically purchases Daratumumab in bulk?
Bulk procurement is commonly undertaken by pharmaceutical importers, hospitals, government procurement agencies, oncology centers, distributors, and healthcare organizations.
What strengths are commonly available?
Daratumumab is commonly supplied in 100 mg/5 mL and 400 mg/20 mL single-dose vials, subject to availability.
What documentation is generally provided for export?
Documentation may include COA, COO, commercial invoices, packing lists, quality-related documents, and additional regulatory certificates based on destination-country requirements.
Does Daratumumab require temperature-controlled shipping?
Yes. As a biologic medicine, transportation requirements should follow applicable storage recommendations and good distribution practices.
Can hospitals procure Daratumumab directly?
Hospitals and authorized procurement organizations may source Daratumumab through compliant pharmaceutical suppliers, subject to local regulations.
Why is India considered a preferred sourcing destination?
India offers a mature pharmaceutical manufacturing ecosystem, established export infrastructure, experienced regulatory support, and efficient international logistics, making it a preferred sourcing hub for specialty medicines.
Conclusion
As the global demand for advanced hematology and oncology therapies continues to grow, reliable sourcing has become increasingly important for healthcare providers, distributors, and procurement organizations worldwide.
Choosing an experienced Daratumumab supplier from India involves evaluating product quality, regulatory documentation, export expertise, and logistics capabilities—not simply price. A dependable sourcing partner can help simplify international procurement while supporting compliance with destination-country requirements.
At Ikris Health Plus, we are committed to assisting global pharmaceutical buyers with professional procurement support, export coordination, and access to specialty oncology medicines for eligible international markets. Whether you are sourcing for hospitals, distributors, government agencies, or healthcare organizations, our team is dedicated to supporting your pharmaceutical supply requirements with reliability, transparency, and efficiency.
